Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Whittier. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Whittier at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This is an open-label, randomized, Phase 2b study of ZEN003694 in combination with enzalutamide vs. enzalutamide monotherapy in patients with mCRPC who have progressed on prior abiraterone by PCWG3 criteria. Disease must have progressed on only abiraterone by PCWG3 criteria prior to study entry. The patient population will be separated into two cohorts: Cohort A: Patients with poor response to prior abiraterone defined as: * Abiraterone started in hormone-sensitive prostate cancer (HSPC) dise
Sponsor: Zenith Epigenetics
Check if you qualify for this prostate cancer clinical trial in Whittier, CA
If you're searching for prostate cancer treatment options in Whittier, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Whittier research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.